← Leaderboards
John C. Alverdy
University Of Chicago
$10,950,673
Attributed
$11,650,673
Total exposure
7
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.5M · FY2005–25$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$11,650,673 · 7
By mechanism
R01$9,168,727 · 1
R42$1,299,066 · 1
R21$447,797 · 1
R41$400,000 · 1
M01$176,733 · 2
R34$158,350 · 1
Top collaborators
- Patrick Hennessey2 shared
Most similar at University Of Chicago
Same institution · by research overlap
- James Lingeman$2,205,353
- Erika C Claud$12,656,656
Others in their field
Top investigators on “Virulence”
- Ronald B Corley · Boston University Medical Campus$43,000,000
- Joseph Heitman · Duke University$29,765,716
- Vanessa Sperandio · University Of Wisconsin-Madison$29,177,087
- Adolfo Garcia-Sastre · Jackson Laboratory$28,883,338
- John J Mekalanos · Harvard Medical School$28,747,360
- Scott J Hultgren · Washington University$28,322,020
Research focus
VirulenceOperative Surgical ProceduresPathogenPhenotypeAntibioticsIn VivoSepsisIntestinesCritical IllnessVirulentStressMolecularInjurySurgical InjuriesMicrobiomeResponsePseudomonas AeruginosaRecoveryTissuesAntibiotic ResistancePlayResistanceGene ExpressionMortality
Grant awards (38)
A novel, non-antibiotic, microbiome-directed agent to prevent post-surgical infection$1,000,000
R42 · FY2025 · AI
Gut pathogen virulence and its therapeutic modulation during surgical injury$466,862
R01 · FY2025 · GM · contact PI
Gut pathogen virulence and its therapeutic modulation during surgical injury$472,361
R01 · FY2024 · GM · contact PI
Preventing chemotherapy-related toxicities and infections with a novel phosphorylated triblock copolymer$400,000
R41 · FY2024 · CA
Gut pathogen virulence and its therapeutic modulation during surgical injury$469,029
R01 · FY2023 · GM · contact PI
A novel, non-antibiotic, microbiome-directed agent to prevent post-surgical infection$299,066
R42 · FY2023 · AI · contact PI
Gut pathogen virulence and its therapeutic modulation during surgical injury$483,800
R01 · FY2022 · GM · contact PI
Gut pathogen virulence and its therapeutic modulation during surgical injury$453,600
R01 · FY2021 · GM · contact PI
Gut pathogen virulence and its therapeutic modulation during surgical injury$11,428
R01 · FY2021 · GM · contact PI
Gut pathogen virulence and its therapeutic modulation during surgical injury$450,580
R01 · FY2020 · GM · contact PI
Gut pathogen virulence and its therapeutic modulation during surgical injury$453,227
R01 · FY2019 · GM · contact PI
Gut pathogen virulence and its therapeutic modulation during surgical injury$453,600
R01 · FY2018 · GM · contact PI
Gut pathogen virulence and its therapeutic modulation during surgical injury$400,037
R01 · FY2017 · GM · contact PI
Gut pathogen virulence and its therapeutic modulation during surgical injury$400,037
R01 · FY2016 · GM · contact PI
Gut pathogen virulence and its therapeutic modulation during surgical injury$400,037
R01 · FY2015 · GM · contact PI
Gut pathogen virulence and its therapeutic modulation during surgical injury$395,817
R01 · FY2014 · GM · contact PI
Serial Endoscopic Surveillance (SES) and Direct Topical Antibiotics (DTA) to prev$158,350
R34 · FY2014 · GM · contact PI
Interplay of diet and the metabolome in establishment of the juvenile gut microbi$236,559
R21 · FY2013 · AI · contact PI
Pseudomonas' effects on the gut barrier from surgery$364,187
R01 · FY2012 · GM · contact PI
Interplay of diet and the metabolome in establishment of the juvenile gut microbi$211,238
R21 · FY2012 · AI · contact PI
Pseudomonas' effects on the gut barrier from surgery$364,186
R01 · FY2011 · GM · contact PI
Pseudomonas' effects on the gut barrier from surgery$386,892
R01 · FY2010 · GM · contact PI
Pseudomonas' effects on the gut barrier from surgery$390,000
R01 · FY2009 · GM · contact PI
Pseudomonas' effects on the gut barrier from surgery$300,041
R01 · FY2008 · GM · contact PI
Pseudomonas' effects on the gut barrier from surgery$362,819
R01 · FY2007 · GM · contact PI
Pseudomonas' effects on the gut barrier from surgery$12,931
R01 · FY2007 · GM · contact PI
Pseudomonas' effects on the gut barrier from surgery$7,687
R01 · FY2007 · GM · contact PI
Pseudomonas' effects on the gut barrier from surgery$309,002
R01 · FY2006 · GM · contact PI
GASTRIC BYPASS EFFECTS ON SLEEP & GLUCOSE REG$10,520
M01 · FY2006 · RR · contact PI
Pseudomonas'effects on the gut barrier from surgery$316,438
R01 · FY2005 · GM
GASTRIC BYPASS EFFECTS ON SLEEP &GLUCOSE REG$29,059
M01 · FY2005 · RR
PSEUDOMONAS'EFFECTS ON THE GUT BARRIER FROM SURGERY$250,660
R01 · FY2004 · GM
Gastric bypass effects on sleep &glucose reg$137,154
M01 · FY2004 · RR
PSEUDOMONAS'EFFECTS ON THE GUT BARRIER FROM SURGERY$250,660
R01 · FY2003 · GM
PSEUDOMONAS'EFFECTS ON THE GUT BARRIER FROM SURGERY$249,723
R01 · FY2002 · GM
PSEUDOMONAS'EFFECTS ON THE GUT BARRIER FROM SURGERY$33,378
R01 · FY2002 · GM
PSEUDOMONAS'EFFECTS ON THE GUT BARRIER FROM SURGERY$9,957
R01 · FY2002 · GM
PSEUDOMONAS'EFFECTS ON THE GUT BARRIER FROM SURGERY$249,751
R01 · FY2001 · GM